The Asia Pacific Pet Diabetes Care Market is expected to witness market growth of 9.2% CAGR during the forecast period (2022-2028).
Regular inspections by a veterinarian could keep the pet healthy and identify issues before they can become serious since older dogs & cats are more prone to acquire age-related diseases or ailments that could be mistaken for diabetes. Additionally, diabetic pets need to be watched for long-term issues like cataracts that frequently appear in diabetic dogs & cats. Other issues that may arise involve low urinary tract infections, high blood pressure (hypertension), and hind leg paralysis brought on by low blood potassium levels (hypokalemia).
The dog or cat's food is easily broken all through digestion so that the body can use them. Several sugars, particularly glucose, are created when carbohydrates are broken down. The blood is filled with glucose, which is ingested from the intestines and gives the body's cells energy. Nevertheless, the presence of the hormone called insulin is necessary for most cells to take up glucose. The body needs insulin to move glucose (sugar) from the blood into the body's cells for energy. Insulin is generally manufactured extracted by the beta cells of the pancreas.
To enhance the overall health of pets, some governments have taken action to encourage the adoption of safe and healthful products. The Law for Ensuring the Safety of Pet Care, that is applicable to pet care makers, importers, and distributors, was enacted by the Japanese government to protect pet health and regulate the manufacturing process. Such actions is expected to boost the pet diabetes care industry as a whole. The regional pet diabetes care market is therefore expected to increase as a result of these factors during the forecast period.
The China market dominated the Asia Pacific Pet Diabetes Care Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $200.1 million by 2028. The Japan market is estimated to grow a CAGR of 8.6% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 9.9% during (2022 - 2028).
Based on Animal Type, the market is segmented into Dogs and Cat. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce. Based on Solution, the market is segmented into Treatment (Insulin Therapy, Insulin Delivery Devices, and Others) and Glucose Monitoring Devices. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Merck & Co., Inc., Zoetis, Inc., ACON Laboratories, Inc., Allison Medical, Inc., i-SENS, Inc., Trividia Health, Inc., UltiMed, Inc., and Taidoc Technology Corporation.
Regular inspections by a veterinarian could keep the pet healthy and identify issues before they can become serious since older dogs & cats are more prone to acquire age-related diseases or ailments that could be mistaken for diabetes. Additionally, diabetic pets need to be watched for long-term issues like cataracts that frequently appear in diabetic dogs & cats. Other issues that may arise involve low urinary tract infections, high blood pressure (hypertension), and hind leg paralysis brought on by low blood potassium levels (hypokalemia).
The dog or cat's food is easily broken all through digestion so that the body can use them. Several sugars, particularly glucose, are created when carbohydrates are broken down. The blood is filled with glucose, which is ingested from the intestines and gives the body's cells energy. Nevertheless, the presence of the hormone called insulin is necessary for most cells to take up glucose. The body needs insulin to move glucose (sugar) from the blood into the body's cells for energy. Insulin is generally manufactured extracted by the beta cells of the pancreas.
To enhance the overall health of pets, some governments have taken action to encourage the adoption of safe and healthful products. The Law for Ensuring the Safety of Pet Care, that is applicable to pet care makers, importers, and distributors, was enacted by the Japanese government to protect pet health and regulate the manufacturing process. Such actions is expected to boost the pet diabetes care industry as a whole. The regional pet diabetes care market is therefore expected to increase as a result of these factors during the forecast period.
The China market dominated the Asia Pacific Pet Diabetes Care Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $200.1 million by 2028. The Japan market is estimated to grow a CAGR of 8.6% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 9.9% during (2022 - 2028).
Based on Animal Type, the market is segmented into Dogs and Cat. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce. Based on Solution, the market is segmented into Treatment (Insulin Therapy, Insulin Delivery Devices, and Others) and Glucose Monitoring Devices. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Merck & Co., Inc., Zoetis, Inc., ACON Laboratories, Inc., Allison Medical, Inc., i-SENS, Inc., Trividia Health, Inc., UltiMed, Inc., and Taidoc Technology Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Animal Type
- Dogs
- Cat
By Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- E-commerce
By Solution
- Treatment
- Insulin Therapy
- Insulin Delivery Devices
- Others
- Glucose Monitoring Devices
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Boehringer Ingelheim International GmbH
- Becton, Dickinson and Company
- Merck & Co., Inc.
- Zoetis, Inc.
- ACON Laboratories, Inc.
- Allison Medical, Inc.
- i-SENS, Inc.
- Trividia Health, Inc.
- UltiMed, Inc.
- Taidoc Technology Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Pet Diabetes Care Market by Animal Type
Chapter 4. Asia Pacific Pet Diabetes Care Market by Distribution Channel
Chapter 5. Asia Pacific Pet Diabetes Care Market by Solution
Chapter 6. Asia Pacific Pet Diabetes Care Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Becton, Dickinson and Company
- Merck & Co., Inc.
- Zoetis, Inc.
- ACON Laboratories, Inc.
- Allison Medical, Inc.
- i-SENS, Inc.
- Trividia Health, Inc.
- UltiMed, Inc.
- Taidoc Technology Corporation
Methodology
LOADING...
